EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 173 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,060,460 | -21.6% | 257,480 | -3.4% | 0.00% | -50.0% |
| Q2 2023 | $5,179,147 | -7.7% | 266,417 | +34.7% | 0.00% | 0.0% |
| Q1 2023 | $5,611,814 | -5.6% | 197,808 | -2.7% | 0.00% | 0.0% |
| Q4 2022 | $5,943,000 | +6.4% | 203,325 | -3.8% | 0.00% | 0.0% |
| Q3 2022 | $5,588,000 | -50.3% | 211,441 | -16.4% | 0.00% | -50.0% |
| Q2 2022 | $11,236,000 | -14.2% | 252,901 | -4.5% | 0.00% | 0.0% |
| Q1 2022 | $13,101,000 | -3.7% | 264,722 | -0.9% | 0.00% | 0.0% |
| Q4 2021 | $13,601,000 | +53.9% | 267,056 | +68.5% | 0.00% | +33.3% |
| Q3 2021 | $8,839,000 | +36.9% | 158,456 | +5.1% | 0.00% | +50.0% |
| Q2 2021 | $6,455,000 | +28.1% | 150,804 | +24.9% | 0.00% | 0.0% |
| Q1 2021 | $5,038,000 | -0.9% | 120,700 | +10.6% | 0.00% | 0.0% |
| Q4 2020 | $5,082,000 | +12.7% | 109,127 | +2.8% | 0.00% | 0.0% |
| Q3 2020 | $4,510,000 | +9.7% | 106,192 | +23.9% | 0.00% | 0.0% |
| Q2 2020 | $4,113,000 | +4.2% | 85,722 | -0.1% | 0.00% | 0.0% |
| Q1 2020 | $3,948,000 | -23.6% | 85,793 | -0.2% | 0.00% | 0.0% |
| Q4 2019 | $5,167,000 | +4.7% | 86,008 | -1.4% | 0.00% | 0.0% |
| Q3 2019 | $4,936,000 | -6.7% | 87,253 | -8.2% | 0.00% | 0.0% |
| Q2 2019 | $5,290,000 | +79.9% | 95,013 | +63.1% | 0.00% | +100.0% |
| Q1 2019 | $2,941,000 | +16.2% | 58,253 | -7.3% | 0.00% | 0.0% |
| Q4 2018 | $2,532,000 | -42.8% | 62,835 | -1.6% | 0.00% | -50.0% |
| Q3 2018 | $4,426,000 | +24.5% | 63,840 | +35.8% | 0.00% | 0.0% |
| Q2 2018 | $3,556,000 | -46.1% | 47,000 | -62.5% | 0.00% | -33.3% |
| Q1 2018 | $6,600,000 | -0.7% | 125,284 | +0.7% | 0.00% | 0.0% |
| Q4 2017 | $6,644,000 | -19.6% | 124,374 | -10.3% | 0.00% | -25.0% |
| Q3 2017 | $8,267,000 | -21.3% | 138,619 | +4.2% | 0.00% | -20.0% |
| Q2 2017 | $10,500,000 | +10.4% | 133,071 | +16.0% | 0.01% | 0.0% |
| Q1 2017 | $9,515,000 | +0.2% | 114,736 | -4.1% | 0.01% | 0.0% |
| Q4 2016 | $9,494,000 | +24.5% | 119,657 | +9.8% | 0.01% | +25.0% |
| Q3 2016 | $7,628,000 | +232.8% | 108,963 | +321.6% | 0.00% | +300.0% |
| Q4 2015 | $2,292,000 | +27.0% | 25,846 | +6.0% | 0.00% | 0.0% |
| Q3 2015 | $1,805,000 | +17.5% | 24,381 | +28.3% | 0.00% | 0.0% |
| Q2 2015 | $1,536,000 | +96.7% | 18,999 | +1.9% | 0.00% | – |
| Q1 2015 | $781,000 | – | 18,652 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 121,014 | $5,377,000 | 1.78% |
| Smith, Graham & Co., Investment Advisors, LP | 232,343 | $10,323,000 | 1.28% |
| GLOBEFLEX CAPITAL L P | 73,205 | $3,252,000 | 0.79% |
| SummerHaven Investment Management, LLC | 18,604 | $827,000 | 0.56% |
| BRANDES INVESTMENT PARTNERS, LP | 464,292 | $20,628,000 | 0.50% |
| Capital Impact Advisors, LLC | 11,728 | $521,000 | 0.48% |
| Watershed Asset Management, L.L.C. | 5,756 | $256,000 | 0.32% |
| Foundry Partners, LLC | 84,325 | $3,747,000 | 0.23% |
| Summit Global Investments | 33,738 | $1,499,000 | 0.13% |
| SCOUT INVESTMENTS, INC. | 147,034 | $6,533,000 | 0.13% |